AVIR

Conviction 47HealthcareScan · Thu, Jun 25, 2026

AVIR$4.35-2.90%

ResistanceSupportVol 14Insider buy

Vol MA14 297.85K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Atea Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.ateapharma.com ↗

Price4.35

Change-2.90%

Gap-1.79%

Rel volume2.28×

Avg volume298.37K

Avg $ vol1.31M

SMA 204.39

SMA 504.85

SMA 2004.13

Price vs 50-10.29%

Price vs 200+5.32%

MA stackmixed

50/200 cross—

Supertrenddown · 4.99

RSI (14)44

MACD hist0.04

MACD cross—

Stoch %K / %D35 / 60

ADX (14)19

+DI / −DI14 / 19

RSI divergence—

MACD divergence—

ATR %+4.83%

ADR %4.69%

52w high6.15

52w low2.82

From 52w high-29.27%

Above 52w low+54.26%

New 52w highNo

SqueezeOn · 5d

Bollinger width11.50%

%B0.42

Donchian pos32.79%

Donchian high4.76

Donchian low4.15

AVWAP (52w high)5.24

vs AVWAP high-16.95%

AVWAP (52w low)4.25

vs AVWAP low+2.37%

OBV trendFlat

Chaikin MF (20)-0.18

Today vs 20d2.28×

Avg vol (14d)297.85K

Avg vol (20d)298.37K

Avg $ vol (20d)1.31M

Market cap348.12M

RS 3m (vs SPY)-28.20%

RS 6m (vs SPY)+34.94%

RS line new highNo

Trend template4/8

Technical rank54.1

1 week+0.46%

1 month-3.97%

3 months-19.89%

6 months+37.22%

1 year+28.70%

YTD+25.00%

P/E-2.20

P/B1.49

P/S0.99

P/FCF-2.60

EPS-1.94

Div yield—

ROE-67.75%

ROA-59.29%

Debt/Eq—

Current7.89

EV/EBITDA-1.49

Gross margin—

Net margin-45.07%

Rev growth0.00%

EPS growth5.96%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value268.8M

Revenue32.81M

Net income-45.44M

Gross profit—

Free cash flow-133.97M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out80.03M

Employees55

ListedFri, Oct 30, 2020

Free float54.52M

Float %69.8%

Short interest7.53M

Days to cover23.9d

Short volume54.9%

Squeeze score78 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast−$0.56 · 2 est

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction47 / 100

Pattern quality—

Tech rank54.1 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.73

Support4.10

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AVIR

All disclosures →

No recent disclosed trades by Congress in AVIR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AVIR · 2 buys

Insider	Side	Shares	Value	Traded	Filed
Murphy Polly A. Director · Common Stock · 2026-05-18	Buy	6.1K	$25K	2026-05-18	2026-05-21
Murphy Polly A. Director · Common Stock · 2025-05-18	Buy	6.1K	$25K	2025-05-18	2026-05-20

SEC filings

EDGAR filings in AVIR · 1 recent

EDGAR →

8-K8-KMon, Jun 22, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.